Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho

被引:12
作者
Kanda, Eiichiro [1 ,2 ]
Al, Masumi [3 ]
Okazaki, Mitsuyo [4 ]
Yoshida, Masayuki [2 ]
Maeda, Yoshitaka [5 ]
机构
[1] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Bunkyo Ku, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Nephrol, Toride, Ibaraki, Japan
来源
PLOS ONE | 2016年 / 11卷 / 11期
关键词
FIBROBLAST GROWTH FACTOR-23; INSULIN-RESISTANCE; PREDIALYSIS PATIENTS; DOWN-REGULATION; RENAL-DISEASE; CHOLESTEROL; RISK; DYSLIPIDEMIA; GENE; METABOLISM;
D O I
10.1371/journal.pone.0166459
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder. High-density lipoproteins (HDLs) are grouped into various subclasses composed of multiple proteins and lipids, and their transformation is altered in CKD. We investigated the roles of lipoprotein subclasses in CKD progression, and atherosclerosis, and the relationships with Klotho and fibroblast growth factor (FGF) 23. Methods Seventy-one CKD patients were enrolled in this prospective cohort study in Japan. The proportions of cholesterol level to total cholesterol level (cholesterol proportion) and lipoprotein particle numbers in 20 lipoprotein fractions were measured by a newly developed high-performance gel permeation chromatography. Results Diabetic nephropathy was observed in 23.9% of the patients. The mean age was 75.0 years and estimated glomerular filtration rate (eGFR) was 17.2 ml/min./1.73m(2). The lipoprotein particle numbers in small HDLs were higher in Stage 4 group than in Stage 5 group (p = 0.002). Multivariate regression analysis adjusted for baseline characteristics showed that the cholesterol proportions in very small HDLs were associated with eGFR change rate [F19 beta = -17.63, p = 0.036] and ABI [F19 beta = 0.047, p = 0.047] in Stage 4 group, and that serum soluble a-Klotho level was associated with the lipoprotein particle numbers in very small HDLs [F19 beta = 0.00026, p = 0.012; F20 beta = 0.00041, p = 0.036] in Stage 5 group. Conclusions This study showed that HDL subclasses are associated with CKD progression, ABI, and Klotho level in CKD-stage-specific manner.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease
    Valdivielso, Jose M.
    Bozic, Milica
    Galimudi, Rajesh Kumar
    Bermudez-Lopez, Marcelino
    Navarro-Gonzalez, Juan F.
    Fernandez, Elvira
    Betriu, Angels
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 2079 - 2088
  • [42] An association of low high-density lipoprotein levels with recurrence of chronic subdural hematoma
    Liu, Wen-Chao
    Lin, Qing-Qing
    Jin, Jing
    Wang, Ming
    You, Wen-Dong
    Gu, Jun
    Pan, Jian-Wei
    [J]. ACTA NEUROCHIRURGICA, 2021, 163 (04) : 1061 - 1068
  • [43] High-Density Lipoprotein Is Associated with Progression of Intracranial Aneurysms
    Huang, Qing
    Shang-Guan, Huang-Cheng
    Wu, Si-Ying
    Yao, Pei-Sen
    Sun, Yi
    Zeng, Yi-Le
    Zheng, Shu-Fa
    Chen, Guo-Rong
    Lin, Yuan-Xiang
    Kang, De-Zhi
    [J]. WORLD NEUROSURGERY, 2018, 120 : E234 - E240
  • [44] High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
    Duprez, Daniel A.
    Otvos, James
    Tracy, Russell P.
    Feingold, Kenneth R.
    Greenland, Philip
    Gross, Myron D.
    Lima, Joao A. C.
    Mackey, Rachel H.
    Neaton, James D.
    Sanchez, Otto A.
    Jacobs, David R., Jr.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (09):
  • [45] Inborn errors of high-density lipoprotein metabolism
    von Eckardstein, Arnold
    [J]. INTERNIST, 2019, 60 (12): : 1311 - 1317
  • [46] Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease
    Savic, Jasna
    Zeljkovic, Aleksandra
    Bogavac-Stanojevic, Natasa
    Simic-Ogrizovic, Sanja
    Kravljaca, Milica
    Stosovic, Milan
    Vekic, Jelena
    Spasojevic-Kalimanovska, Vesna
    Jelic-Ivanovic, Zorana
    Gojkovic, Tamara
    Spasic, Slavica
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (07) : 637 - 643
  • [47] Association between triglyceride to high-density lipoprotein cholesterol ratio and microalbuminuria in the Chinese population
    Zhang, Xue
    Hu, Haofei
    He, Lishu
    Huang, Xia
    Zhang, Zhichao
    Tu, Lirong
    Zhang, Heping
    Liu, Feiyuan
    Liu, Xiaohui
    He, Yongcheng
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study
    Pan, Jingjing
    Li, Changnian
    Zhang, Jiayi
    Sun, Zhenhua
    Yu, Xiaoying
    Wan, Qianhui
    Ruan, Zhishen
    Wang, Wenbo
    Li, Yujie
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [49] Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease
    Park, Joo-Hyun
    Lee, Chung-Woo
    Nam, Myung Ji
    Kim, Hyunjin
    Kwon, Do-Young
    Yoo, Ji Won
    Lee, Kyu Na
    Han, Kyungdo
    Jung, Jin-Hyung
    Park, Yong-Gyu
    Kim, Do-Hoon
    [J]. NEUROLOGY, 2021, 96 (10) : E1391 - E1401
  • [50] Association of cumulative non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with the risk of cardiometabolic disease
    Liu, Luqing
    Liu, Shihe
    Liao, Yicheng
    Zhang, Xiaoxue
    Wang, Meixiao
    Lin, Liming
    Zhu, Chenrui
    Wu, Shouling
    Wu, Yuntao
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11